Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
BREAKING NEWS
- From fintech to aesthetic injectables: Lessons in navigating regulatory formalisation
- Karnataka holds 64th Vision Group on Biotechnology meeting to review biotech ecosystem
- Glenmark launches Methylene Blue Injection USP in US
- ILAMED expands international presence with centres in Kenya, Ethiopia and Thailand
- Novartis India launches Pluvicto for PSMA-positive metastatic prostate cancer
- Alembic receives USFDA final approval for Tretinoin Cream USP, 0.05%
- Ipca Laboratories and Bhami’s Research Laboratory signs global licensing agreement for subcutaneous biologics platform
- CDSCO’s cosmetic regulations: The rules exist. The enforcement does not
- Why ingredient transparency matters more than ever in cosmeceuticals
- Indore Pharma Summit: Mapping the future of India pharma
Rishi Agrawal, CEO, TeamLease RegTech cautions that the recent CDSCO clarification on injectable cosmetic products signals a broader shift toward accountability and risk-based regulation for the aesthetics industry.
Meeting discusses biotechnology strategy, AI integration, biomanufacturing and financing ecosystem
Generic injectable approved as bioequivalent to ProvayBlue Injection 50 mg/10 mL
Institute to launch Cairo centre in September 2026 as part of its overseas expansion
Radioligand therapy approved for eligible patients with PSMA-positive prostate cancer in India
Rishi Agrawal, CEO, TeamLease RegTech cautions that the recent CDSCO clarification on injectable cosmetic products signals a…
Meeting discusses biotechnology strategy, AI integration, biomanufacturing and financing ecosystem
Generic injectable approved as bioequivalent to ProvayBlue Injection 50 mg/10 mL
Institute to launch Cairo centre in September 2026 as part of its overseas expansion
Radioligand therapy approved for eligible patients with PSMA-positive prostate cancer in India
ANDA approved for Tretinoin Cream USP, 0.05%, referencing Retin-A Cream, 0.05%
Agreement enables development and commercialisation of monoclonal antibody products for oncology and inflammatory diseases using…
People have died in India’s aesthetic clinics. Not in rare surgical catastrophes, but in routine cosmetic procedures performed by…
LATEST NEWS
Editors' Picks
Popular now
Articles By Authors
Videos
world
From fintech to aesthetic injectables: Lessons in navigating regulatory…
Rishi Agrawal, CEO, TeamLease RegTech cautions that the recent CDSCO…
Sport
From fintech to aesthetic injectables: Lessons in navigating regulatory…
Rishi Agrawal, CEO, TeamLease RegTech cautions that the recent CDSCO…
technology
Recent Posts